Recombinant Human M-CSF, Animal-Free Protein
R&D Systems, part of Bio-Techne | Catalog # AFL216
Intended for preclinical researchers who may transition to GMP M-CSF for their clinical work
Key Product Details
Learn more about Animal-Free Recombinant Proteins
Source
E. coli
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
E. coli-derived human M-CSF protein
Glu33-Ser190, with an N-terminal Met
Produced using non-animal reagents in an animal-free laboratory.
Glu33-Ser190, with an N-terminal Met
Produced using non-animal reagents in an animal-free laboratory.
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met
Predicted Molecular Mass
18.5 kDa (monomer)
SDS-PAGE
37 kDa, non-reducing conditions
Activity
Measured in a cell proliferation assay using M-NFS-60 mouse myelogenous leukemia lymphoblast cells. Nakoinz, I. et al. (1990) J. Immunol. 145:860.
The ED50 for this effect is 0.5-1.5 ng/mL.The specific activity of Recombinant Human M-CSF is >6.0 x 107 IU/mg, which is calibrated against the human M-CSF WHO International Standard (NIBSC code: 89/512).
The ED50 for this effect is 0.5-1.5 ng/mL.The specific activity of Recombinant Human M-CSF is >6.0 x 107 IU/mg, which is calibrated against the human M-CSF WHO International Standard (NIBSC code: 89/512).
Formulation, Preparation and Storage
AFL216
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 0.2 mg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: M-CSF
References
- Pixley, F.J. and E.R. Stanley (2004) Trends Cell Biol. 14:628.
- Chitu, V. and E.R. Stanley (2006) Curr. Opin. Immunol. 18:39.
- Fixe, P. and V. Praloran (1997) Eur. Cytokine Netw. 8:125.
- Ryan, G.R. et al. (2001) Blood 98:74.
- Makrigiannakis, A. et al. (2006) Trends Endocrinol. Metab. 17:178.
- Nandi, S. et al. (2006) Blood 107:786.
- Rettenmier, C.W. and M.F. Roussel (1988) Mol. Cell Biol. 8:5026.
- Suzu, S. et al. (1992) J. Biol. Chem. 267:16812.
- Manos, M.M. (1988) Mol. Cell. Biol. 8:5035.
- Koths, K. (1997) Mol. Reprod. Dev. 46:31.
- Jang, M-H. et al. (2006) J. Immunol. 177:4055.
- Kawasaki, E.S. et al. (1985) Science 230: 291.
- Wong, G.G. et al. (1987) Science 235:1504.
Long Name
Macrophage Colony Stimulating Factor
Alternate Names
CSF-1, CSF1, Lanimostim, MCSF
Gene Symbol
CSF1
UniProt
Additional M-CSF Products
Product Documents for Recombinant Human M-CSF, Animal-Free Protein
Manufacturing Specifications
Animal-Free Manufacturing ConditionsOur dedicated controlled-access animal-free laboratories ensure that at no point in production are the products exposed to potential contamination by animal components or byproducts. Every stage of manufacturing is conducted in compliance with R&D Systems' stringent Standard Operating Procedures (SOPs). Production and purification procedures use equipment and media that are confirmed animal-free.
Production
- All molecular biology procedures use animal-free media and dedicated labware.
- Dedicated fermentors are utilized in committed animal-free areas.
Purification
- Protein purification columns are animal-free.
- Bulk proteins are filtered using animal-free filters.
- Purified proteins are stored in animal-free containers in a dedicated cold storage room.
- Low Endotoxin Level.
- No impairment of biological activity.
- High quality product obtained under stringent conditions.
- For ex vivo research or bioproduction, additional documentation can be provided.
Product Specific Notices for Recombinant Human M-CSF, Animal-Free Protein
For research use or further manufacturing only
Loading...
Loading...
Loading...